Elzhina

Composition: Neomycin, Ornidazole, Prednisolone, Econazole

Form: Vaginal tablets

Indications: Bacterial vaginitis, candidal vulvovaginitis, mixed etiology vaginitis.

Contraindications: Hypersensitivity to components, CNS disorders, blood pathologies, pregnancy, breastfeeding, under 18 years of age.

Dosage: 1 vaginal tablet once daily at bedtime. Course duration: 6 to 9 days.

Side effects: Burning, irritation, swelling at the site of administration, vaginal dryness, contact dermatitis, rash, urticaria. Rarely — angioedema.

Interactions: Unlikely interaction with other drugs. Use with caution with warfarin and acenocoumarol (oral anticoagulants).

Warnings: For intravaginal use only. Do not ingest. Avoid sexual intercourse during treatment. Tablet remnants may remain in the vagina — this does not affect efficacy.

Age restrictions: 18+

Pregnancy: Contraindicated during pregnancy and lactation

Country of origin: Russia

Manufacturer: VERTEX JSC

Storage conditions: Store at temperatures not exceeding 25°C, in a dry place out of reach of children and protected from light.